Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J.-Y.
Right arrow Articles by Carr, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J.-Y.
Right arrow Articles by Carr, T. P.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:3239-3244, December 2004

Biochemical and Molecular Actions of Nutrients

Dietary Fatty Acids Regulate Acyl-CoA:Cholesterol Acyltransferase and Cytosolic Cholesteryl Ester Hydrolase in Hamsters1,2

Ji-Young Lee and Timothy P. Carr3

Department of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE 68583

3To whom correspondence should be addressed. E-mail: tcarr2{at}unl.edu.


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
To investigate the effects of dietary fatty acids on acyl-CoA:cholesterol acyltransferase (ACAT) and cytosolic cholesteryl ester hydrolase (cCEH), male Syrian hamsters (F1B hybrid) were fed a modified version of the NIH-07 open formula, cereal-based rodent diet enriched with one of the following 4 dietary fatty acids: palmitic acid (16:0), trans fatty acids (18:1t), oleic acid (18:1c), or linoleic acid (18:2). Hamsters fed 16:0 and 18:1t had significantly higher plasma non-HDL cholesterol concentrations compared with those fed 18:1c and 18:2. However, differences in plasma apolipoprotein (apo)B100 concentration, hepatic cCEH mRNA abundance, and hepatic ACAT activity between 16:0- and 18:1t-fed hamsters suggest that the hypercholesterolemic effects are achieved by different mechanisms. Specifically, an increase in ACAT activity by 16:0 may induce enrichment of cholesteryl esters in apoB100-containing particles, whereas 18:1t may increase the number of the particles. Hepatic cholesteryl esters accumulated in the 18:1c- and 18:2-fed groups with no differences in hepatic ACAT activity and cCEH mRNA abundance among hamsters fed unsaturated fatty acids (i.e., 18:1t, 18:1c, and 18:2). Considering the lack of change in free cholesterol concentration and increased cholesteryl esters in the liver, the hypocholesterolemic effect of 18:1c and 18:2 compared with 18:1t may be attributed to decreased production of apoB100-containing particles. ACAT-1 was expressed in all the tissues examined; in contrast, ACAT-2 was highly expressed in the liver and small intestine. Hepatic ACAT activity was disproportionate to the levels of ACAT-1 and ACAT-2 mRNA and protein, indicating post-transcriptional regulation of ACAT by dietary fatty acids. The data suggest that cholesterolemic effects of individual dietary fatty acids can be achieved through their independent modulation of pathways regulating assembly and secretion of apoB100-containing particles.

KEY WORDS: • trans fatty acids • cholesterol • acyl-CoA:cholesterol acyltransferase • cholesteryl ester hydrolase • hamsters

The liver plays a major role in maintaining whole-body cholesterol homeostasis, i.e., it is the major site for elimination of cholesterol from the body via bile, either through conversion of cholesterol into bile acids or direct biliary cholesterol secretion. The liver also produces VLDL, and it is a major catabolic site for LDL through the LDL receptor–mediated pathway (1,2). Hepatic free cholesterol concentration was suggested to be a signal to trigger the transcriptional regulatory pathways in cholesterol metabolism through sterol-regulatory element binding protein (SREBP)4 (3). Furthermore, it was shown that VLDL formation increases as hepatic cholesteryl ester synthesis is induced (4). In this way, mechanisms that influence hepatic free cholesterol and cholesteryl ester levels in the liver are important for maintaining body cholesterol homeostasis.

Acyl-CoA:cholesterol acyltransferase (ACAT) is an integral enzyme present in the rough endoplasmic reticulum (ER) that catalyzes the formation of cholesteryl esters from cholesterol and fatty acyl coenzyme A (5,6). Two isoforms of ACAT (named ACAT-1 and ACAT-2) were identified to date in several species including humans (7,8), nonhuman primates (9), and mice (10,11). ACAT-1 is ubiquitously expressed with its active site oriented toward the cytosol. The main function of ACAT-1 is to prevent the excess accumulation of free cholesterol within cell membranes. In contrast, ACAT-2 is expressed mainly in the liver and intestine with its active site in the lumen of the ER, suggesting that ACAT-2 may play a primary role in hepatic lipoprotein synthesis and secretion (4,12) and cholesterol absorption in the small intestine (6,13). Although the structure and general function of the ACAT enzymes are well defined, the factors that regulate ACAT activity are still unclear. Cholesterol availability (14,15), allosteric regulation (16,17), and post-transcriptional regulation (18,19) were suggested to regulate ACAT.

In contrast to the function of ACAT, cholesteryl ester hydrolase (CEH) converts cholesteryl esters to free cholesterol when cellular free cholesterol levels are depressed. CEH and ACAT thus participate in cyclic reactions that are necessary to maintain cellular free cholesterol at a relatively constant level. Among several CEH enzymes present in cells, neutral cytosolic CEH (cCEH) is the key enzyme required for releasing free cholesterol from intracellular cholesteryl ester storage and is thus involved in a tight regulation of the cellular free cholesterol pool (20,21). Responding to cellular free cholesterol levels, cCEH is regulated similarly to 3-hydroxy-3-methyl-glutaryl-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, and oppositely to ACAT (22). The regulation of cCEH in the liver is mainly at the transcriptional level (22,23). Because ACAT and cCEH act together in a cyclic and opposite manner, these enzymes are likely to be coordinately regulated.

Dietary fatty acids influence several aspects of cholesterol metabolism including cholesterol absorption, bile acid synthesis, biliary cholesterol secretion, hepatic VLDL synthesis, and LDL clearance from the circulation. With respect to plasma cholesterol concentration, SFA are generally considered to be hypercholesterolemic compared with dietary carbohydrate, whereas monounsaturated fatty acids are thought to be neutral or mildly hypocholesterolemic, and PUFA are hypocholesterolemic (24,25). Categorizing dietary fatty acids according to degree of saturation has been useful in developing dietary recommendations, although individual fatty acids within the same saturation category can have very different and specific effects on cholesterol metabolism (26–28).

In the present study, we investigated the extent to which dietary fatty acids influence cholesterol esterification and cholesteryl ester hydrolysis in the liver to help explain the hypo- or hypercholesterolemic effect of individual dietary fatty acids. We focused our attention on 4 fatty acids commonly found in the U.S. food supply, i.e., palmitic acid (16:0), trans fatty acid (18:1t), oleic acid (18:1c), and linoleic acid (18:2) fed to hamsters. Hamsters are an excellent animal model for the study of cholesterol metabolism because their plasma lipoprotein distribution and metabolic response to dietary fatty acids are similar to those of humans (2,24,29).


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 LITERATURE CITED
 
    Animals and diets. Male F1B Syrian hamsters weighing ~80 g were purchased from Bio Breeders and housed individually in a temperature-controlled room (25°C) with a 12-h light:dark cycle. Hamsters consumed ad libitum a modified version of the NIH-07 open formula, cereal-based rodent diet (30) containing 170 g fat/kg diet and 0.5 g cholesterol/kg diet (62 nmol cholesterol/kJ) prepared by Dyets, according to our specifications. Four diets were created by blending vegetable oils to achieve an enrichment (300 g/kg total oil) of one of the following fatty acids: 16:0, 18:1t, 18:1c, or 18:2. Detailed diet formulation and composition were published previously (31). The trans fatty acids used in this study were derived from hydrogenated soybean oil and were primarily 18:1 isomers. Hence, we used the abbreviation 18:1t to refer to trans fatty acids. All experimental procedures were approved by the Institutional Animal Care and Use Committee at the University of Nebraska.

    Experimental design. Hamsters were randomly assigned to diet groups of n = 7, except the 16:0 group, which contained 6 hamsters. Food intake and body weight were recorded weekly for the duration of the 4-wk experiment. Food was removed 24 h before the hamsters were killed. The hamsters were anesthetized under CO2 and the abdomen was opened by incision. Blood was collected by cardiac puncture and plasma obtained as previously described (31). Livers were perfused with saline, removed from the animals, and weighed. All liver, small intestine, kidney, aorta, spleen, lung, heart, adipose tissue, adrenal, and testis samples from each hamster were quickly frozen in liquid nitrogen and stored at –70°C.

    Plasma lipids and apolipoprotein B100. Plasma total cholesterol and triacylglycerol concentrations were determined enzymatically (32) using reagents from Roche Diagnostics. Plasma HDL cholesterol concentration was measured after apolipoprotein B100 (apoB100) precipitation (Sigma Diagnostics). Plasma "non-HDL" cholesterol concentration was calculated by subtracting plasma HDL cholesterol from total cholesterol concentration. We showed previously that the non-HDL fraction contains >90% LDL cholesterol in hamsters (33). ApoB100 concentration in the plasma was determined immunoturbidimetrically (Sigma Diagnostics, St. Louis, MO).

    Liver lipids. Lipids were extracted from liver into chloroform:methanol (2:1, v:v) by the method of Folch et al. (34). Enzymatic analysis was performed to measure hepatic free cholesterol (Wako Chemicals), total cholesterol, and triacylglycerol (Roche Diagnostics) (32). Phospholipid concentration in the liver was also determined enzymatically (Kit #990-54009, Wako Chemicals).

    ACAT activity. Microsomes were prepared as previously described (35), and protein concentration was determined for each preparation using the method of Lowry et al. (36). ACAT activity was quantified using a constant amount of microsomal protein; in addition, excess free cholesterol was added to reaction mixtures to eliminate the effect of substrate availability on enzyme activity (35).

    RT-PCR. Total RNA was isolated from 10 different hamster tissues including liver, kidney, lung, heart, small intestine, aorta, spleen, testis, adipose, and adrenal using TRIzol reagent (Life Technologies) according to the manufacturer’s protocol. First-strand cDNA was prepared using AMV RT (Fisher BioReagents) primed with random primers according to manufacturer’s instruction. PCR was performed using Taq DNA polymerase (Takara). For hamster ACAT-1, a 767-base pair (bp) fragment was amplified using forward (5'-AAT CCT GAG CAA GAT GAA GCC CAGA-3') and reverse (5'-ACT CTC GGC ACA TTC TCT CTG-3') primers. An 813-bp hamster ACAT-2 fragment was amplified using forward (5'-CTG GCC ATC GAC TTC ATT GAT GAG-3') and reverse (5'-TAG CTG TAC AGC CAG TCA TGG ACCA-3') primers. Amplification was conducted of a 378-bp ß-actin fragment as an internal control using forward (5'-TCT GGC ACC ACA CCT TCT AC-3') and reverse (5'-CAC GCA CAA TTT CCC TCTC-3') primers. A 448-bp cytosolic CEH cDNA fragment was also amplified using forward (5'-TTC CAC AAT GCG CCT CTA CC-3') and reverse (5'-ACC CAC TAC CAA TCC ACC TC-3') primers. Anti-sense RNA probes were subsequently prepared by in vitro transcription of each cDNA using the Riboprobe system (Promega). The 307-, 400-, 543-, and 290-base in vitro transcription products were produced for ACAT-1, ACAT-2, cytosolic CEH, and ß-actin, respectively. Probes were stored at –70°C until they were used.

    RNase protection assay. The RNase protection assay was performed using RPA III kit (Ambion) following the manufacturer’s protocol. Briefly, each reaction contained 40 µg of liver total RNA, 0.012 MBq of each probe, and 20 µg tRNA in a final volume of 50 µL. After hybridization overnight at 56°C and subsequent RNase digestion, RNase-protected fragments were separated on polyacrylamide/urea gels and exposed on a phosphoimager cassette for 24 h. The intensity of bands was quantified using ImageQuant software (Amersham Biosciences). The same procedure was used to measure the mRNAs for cytosolic CEH and ß-actin.

    Statistical analysis. All results were expressed as means ± SEM. Dietary treatment effect was analyzed using one-way ANOVA, and pairwise comparisons between means were assessed by the Student-Newman-Keuls procedure using GraphPad Prism software. Differences were considered significant at P < 0.05.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 LITERATURE CITED
 
Weekly recorded body weight and food intake did not differ among the 4 groups throughout the 4-wk study period (data not shown). Hamster body weight indicated a mean growth rate of 6–7 g/wk in all groups.

Plasma total cholesterol concentrations were significantly higher in hamsters fed 16:0 and 18:1t compared with those fed 18:1c and 18:2 (not shown). Increased plasma total cholesterol concentrations in the 16:0- and 18:1t-fed groups were due exclusively to an increase in plasma non-HDL cholesterol because plasma HDL cholesterol concentrations did not differ among the 4 groups (Table 1). Plasma triacylglycerol and apoB100 concentrations were significantly higher in 18:1t-fed hamsters than in the other groups.


View this table:
[in this window]
[in a new window]
  		TABLE 1 Plasma lipid and apoB100 concentrations in hamsters fed NIH-07 diets enriched in various fatty acids1, 2

 
Hepatic free cholesterol concentrations did not differ among the 4 groups, whereas a large accumulation of cholesteryl ester occurred in the livers of hamsters fed 18:1c- and 18:2-enriched diets (Table 2). Dietary fatty acids did affect the hepatic phospholipid concentration. The hepatic triacylglycerol concentration in 18:1t-fed hamsters was significantly lower than that of the 18:2-fed group.


View this table:
[in this window]
[in a new window]
  		TABLE 2 Liver lipid concentrations in hamsters fed NIH-07 diets enriched in various fatty acids1, 2

 
The greater plasma non-HDL cholesterol concentrations in the 16:0 and 18:1t groups may be due to the upregulation of hepatic ACAT activity by dietary fatty acids, consequently inducing the formation and secretion of VLDL. To investigate this possibility, the effects of dietary fatty acids on hepatic ACAT expression and activity were measured. RT-PCR analysis was conducted to identify the presence of ACAT-1 and ACAT-2 in hamster tissues (Fig. 1). ACAT-1 was expressed in all of the tissues examined including liver, kidney, lung, heart, aorta, spleen, small intestine, testis, adipose tissue, and adrenal. In contrast, ACAT-2 was expressed mainly in the liver and small intestine. The expression patterns of ACAT-1 and ACAT-2 in hamsters are consistent with those of monkeys (9) and mice (10). Hamsters fed 16:0 had significantly higher total hepatic ACAT activity than the other groups (Fig. 2). To further investigate the regulatory mechanism of ACAT activity by dietary fatty acids, the mRNA abundance of ACAT-1 and ACAT-2 was estimated by RNase protection assay. In spite of significant differences in hepatic ACAT activity, there were no significant differences in either ACAT-1 or ACAT-2 mRNA abundance among the groups (data not shown). Furthermore, ACAT-1 and ACAT-2 protein levels in the liver did not differ among the groups (data not shown). These findings suggest that ACATs are regulated post-translationally by dietary fatty acids.



View larger version (48K):
[in this window]
[in a new window]
  		FIGURE 1 Tissue expression patterns of hamster ACAT-1 and ACAT-2 by RT-PCR analysis. First strand cDNA was prepared from total RNA extracted from 10 hamster tissues using AMV reverse transcriptase. Using cDNA as templates, 767-bp ACAT-1 and 813-bp ACAT-2 DNA fragments were amplified by PCR. ß-Actin was used as an internal control.

 


View larger version (16K):
[in this window]
[in a new window]
  		FIGURE 2 Enzymatic activity of liver ACAT-1 and ACAT-2 in hamsters fed NIH-07 diets enriched in various fatty acids. Microsomes were isolated from hamster livers and ACAT activity was measured as described in Materials and Methods. Values are means ± SEM, n = 6. Bars with different letters are significantly different, P < 0.05.

 
We also measured mRNA abundance of cCEH to determine whether dietary fatty acids regulate its expression at the transcriptional level. Hamsters fed 16:0 had significantly lower hepatic cytosolic CEH mRNA abundance than the other groups (Fig. 3).



View larger version (40K):
[in this window]
[in a new window]
  		FIGURE 3 Cytosolic CEH mRNA abundance in livers of hamsters fed NIH-07 diets enriched in various fatty acids. Cytosolic CEH mRNA abundance in livers from hamsters fed the 4 diets was determined by RNase protection assay. Intensities of protected fragments corresponding to 447-bp cytosolic CEH and 222-bp ß-actin were quantified using Phosphorimager analysis. ß-Actin was used as an internal control and data were expressed as a ratio of cytosolic CEH to ß-actin mRNAs. Values are means ± SEM, n = 6. Bars with different letters are significantly different, P < 0.05.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
LITERATURE CITED
 
The concentration of plasma cholesterol associated with non-HDL lipoproteins (primarily LDL) was significantly increased in hamsters fed 16:0 and 18:1t compared with 18:1c and 18:2. The hypercholesterolemic effect of dietary 16:0 is well established (37), whereas studies in humans and animals showed inconsistent results for dietary 18:1t (38–42). In this study, dietary 18:1t significantly increased plasma non-HDL cholesterol concentration to a similar extent as 16:0. Although both 16:0 and 18:1t are hypercholesterolemic, the mechanisms by which they increase plasma cholesterol concentration appear to be quite different. Plasma apoB100 concentration was significantly higher in 18:1t-fed hamsters than in those fed 16:0, suggesting that the apoB100-containing lipoproteins in the group fed 16:0 were enriched with cholesterol relative to apoB100. Indeed, the non-HDL cholesterol:apoB100 molar ratio was 5376 ± 402 in the group fed 16:0 group and 3483 ± 418 in those fed 18:1t. Therefore, the hypercholesterolemic effect of 16:0 was due, at least in part, to the presence of larger cholesterol-enriched non-HDL lipoproteins, whereas the hypercholesterolemic effect of 18:1t was due to the presence of more lipoprotein particles (indicated by apoB100 concentration). These data suggest that the hepatic production of apoB100-containing lipoproteins is regulated differentially by dietary 16:0 and 18:1t.

A major difference between 16:0 and 18:1t was their regulation of hepatic ACAT and cCEH. Hamsters fed 16:0 had significantly higher hepatic ACAT activity and lower cCEH mRNA abundance than those fed 18:1t, leading us to expect a greater accumulation of cholesteryl esters in the liver in hamsters fed 16:0 compared with those fed 18:1t. However, hepatic cholesteryl ester concentrations did not differ between these 2 groups. Accepting the hypothesis that ACAT-2, not ACAT-1, is responsible for VLDL secretion (43), it is possible that 16:0 may increase ACAT-2 activity and consequently result in the incorporation of cholesteryl esters into VLDL particles, which shifts cholesteryl esters from the liver to the circulation. Because of the differential regulation of ACAT and cCEH by 16:0 and 18:1t, we speculate that 16:0 may increase a pool of cholesteryl esters for VLDL assembly by activating ACAT-2 and inhibiting cCEH, thus producing larger cholesteryl ester-enriched VLDL particles. Alternatively, 18:1t may enhance the synthesis or stability of apoB100, increasing the number of particles. Further study with selective inhibition of ACAT-1 or ACAT-2 will help clarify this. Although the relation between LDL particle composition and atherogenicity remains unresolved (44), there is little doubt that dietary fatty acids can influence the composition of plasma LDL by regulating the lipid content of lipoproteins secreted by the liver (35,45,46).

The present data also confirm the cholesterol-lowering properties of dietary 18:1c and 18:2 by decreasing plasma non-HDL cholesterol concentration compared with 16:0 and 18:1t. The significant accumulation of cholesteryl esters in the livers of 18:1c- and 18:2-fed hamsters should be noted. Other studies also reported that dietary 18:1c and 18:2 induce hepatic cholesteryl ester accumulation compared with SFA (45–48). Because unsaturated fatty acids are preferred fatty acid substrates for ACAT (49), it is possible that feeding 18:1c and 18:2 increases ACAT activity, consequently increasing the cholesteryl ester concentration in the liver. However, hepatic ACAT activity was lower in hamsters fed 18:1c and 18:2 compared with those fed 16:0. A more likely explanation is that increased hepatic cholesteryl ester concentration in hamsters fed 18:1c and 18:2 is due in part to the inhibition of VLDL secretion by 18:1c and 18:2. Possible reductions in VLDL secretion could be a mechanism responsible for the hypocholesterolemic effect in hamsters fed 18:1c and 18:2. LDL receptor knockout mice were studied in this regard because the concentration of non-HDL cholesterol should reflect VLDL secretion in this model. Xie et al. (50) reported that 18:1c and 18:2 increased both hepatic cholesteryl ester concentration and plasma non-HDL cholesterol concentration in LDL receptor knockout mice, indicating that the hypocholesterolemic effect of 18:1c and 18:2 is due to increased LDL receptor-mediated catabolism of plasma LDL independent of regulation of VLDL secretion by these fatty acids. Considering that LDL receptors are regulated mainly at the transcriptional level by SREBP in response to cellular cholesterol concentration (51,52), it does not seem the case in our study because hepatic free cholesterol concentrations did not differ among the 4 groups. However, we cannot rule out the following possibilities: 1) the transcriptional regulation of LDL receptors could be achieved by mechanisms independent of the cellular cholesterol regulatory pool; 2) dietary fatty acids could redistribute free cholesterol into a putative cholesterol regulatory pool within a cell without a change in total cellular free cholesterol concentration, thus affecting LDL receptor activity, (53); or 3) LDL could be taken up by the liver by non-LDL receptor-mediated pathways (54). These possibilities notwithstanding, our data suggest that the primary mechanism whereby dietary 18:1c and 18:2 decreased plasma cholesterol concentration was by reduced VLDL secretion rather than increased LDL clearance.

The regulatory mechanisms of ACAT activity are not fully understood. Cholesterol availability may be one of the regulatory mechanisms for ACAT activity (14,15). However, our study did not support this possibility. Microsomal cholesterol concentrations, which can be an indication of cholesterol in the ER where ACAT-1 and ACAT-2 reside, did not differ among the 4 groups in spite of significantly higher ACAT activity in hamsters fed 16:0 than in the other groups. Therefore, mechanisms other than cholesterol availability may play a major role in the regulation of ACAT activity by dietary fatty acids. Although hepatic ACAT activity was significantly higher in 16:0-fed hamsters, significant differences were not found in either ACAT-1 or ACAT-2 mRNA and protein levels. These results suggest that ACAT activity is regulated at the post-transcriptional level as reported in several other studies (15,18,19).

In conclusion, different types of dietary fatty acids clearly have variable and independent effects on plasma cholesterol concentration. The hypercholesterolemic effect of dietary 16:0 was likely due to the enrichment of cholesteryl esters in apoB100-containing particles secreted by the liver, whereas 18:1t increased the number of lipoprotein particles. The effects of 16:0 and 18:1t on hepatic lipoprotein assembly and/or secretion are achieved in part by the differential regulation of ACAT and cCEH. Conversely, the hypocholesterolemic effect of the unsaturated fatty acids, 18:1c and 18:2, is likely due to their inhibition of hepatic lipoprotein assembly and/or secretion. These data suggest that regulation of plasma cholesterol concentration by individual dietary fatty acids can be achieved through their independent mechanisms of assembly and secretion of apoB100-containing particles.


   FOOTNOTES
 
1 Presented in abstract form at Experimental Biology 01, April 2001, Orlando, FL [Lee, J.-Y., Illston, B. J. & Carr, T. P. (2001) Regulation of acyl-CoA:cholesterol acyltransferase activity and gene expression by fatty acids in hamsters. FASEB J. 15: A289 (abs.)]. Back

2 Supported by the Nebraska Agricultural Research Division (Journal Series No. 14,668). Back

4 Abbreviations used: ACAT, acyl-CoA:cholesterol acyltransferase; apoB100, apolipoprotein B100; cCEH, cytosolic cholesteryl ester hydrolase; ER, endoplasmic reticulum; SREBP, sterol-regulatory element binding protein; 16:0, palmitic acid; 18:1t, trans fatty acid, 18:1c, oleic acid; 18:2, linoleic acid. Back

Manuscript received 7 July 2004. Initial review completed 26 August 2004. Revision accepted 9 September 2004.


   LITERATURE CITED
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 

1. Spady, D. K., Bilheimer, D. W. & Dietschy, J. M. (1983) Rates of receptor-dependent and independent low density lipoprotein uptake in the hamster. Proc. Natl. Acad. Sci. U.S.A. 80:3499-3503.[Abstract/Free Full Text]

2. Spady, D. K. & Dietschy, J. M. (1985) Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster. Proc. Natl. Acad. Sci. 82:4526-4530.[Abstract/Free Full Text]

3. Brown, M. S. & Goldstein, J. L. (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340.[Medline]

4. Huff, M. W., Telford, D. E., Barrett, P. H., Billheimer, J. T. & Gillies, P. J. (1994) Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet. Arterioscler. Thromb. 14:1498-1508.[Abstract/Free Full Text]

5. Balasubramaniam, S., Venkatesan, S., Mitropoulos, K. A. & Peters, T. J. (1978) The submicrosomal localization of acyl-coenzyme A-cholesterol acyltransferase and its substrate, and of cholesteryl esters in rat liver. Biochem. J. 174:863-872.[Medline]

6. Haugen, R. & Norum, K. R. (1976) Coenzyme-A-dependent esterification of cholesterol in rat intestinal mucosa. Scand. J. Gastroenterol. 11:615-621.[Medline]

7. Chang, C. C., Huh, H. Y., Cadigan, K. M. & Chang, T. Y. (1993) Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 268:20747-20755.[Abstract/Free Full Text]

8. Oelkers, P., Behari, A., Cromley, D., Billheimer, J. T. & Sturley, S. L. (1998) Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J. Biol. Chem. 273:26765-26771.[Abstract/Free Full Text]

9. Anderson, R. A., Joyce, C., Davis, M., Reagan, J. W., Clark, M., Shelness, G. S. & Rudel, L. L. (1998) Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem. 273:26747-26754.[Abstract/Free Full Text]

10. Cases, S., Novak, S., Zheng, Y. W., Myers, H. M., Lear, S. R., Sande, E., Welch, C. B., Lusis, A. J., Spencer, T. A., Krause, B. R., Erickson, S. K. & Farese, R. V., Jr (1998) ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J. Biol. Chem. 273:26755-26764.[Abstract/Free Full Text]

11. Uelmen, P. J., Oka, K., Sullivan, M., Chang, C. C., Chang, T. Y. & Chan, L. (1995) Tissue-specific expression and cholesterol regulation of acylcoenzyme A:cholesterol acyltransferase (ACAT) in mice. Molecular cloning of mouse ACAT cDNA, chromosomal localization, and regulation of ACAT in vivo and in vitro. J. Biol. Chem. 270:26192-26201.[Abstract/Free Full Text]

12. Carr, T. P., Hamilton, R. L., Jr & Rudel, L. L. (1995) ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. J. Lipid Res. 36:25-36.[Abstract]

13. Norum, K. R., Lilljeqvist, A. C. & Drevon, C. A. (1977) Coenzyme-A-dependent esterification of cholesterol in intestinal mucosa from guinea-pig. Influence of diet on the enzyme activity. Scand. J. Gastroenterol. 12:281-288.[Medline]

14. Billheimer, J. T. & Gillies, P. J. (1990) Intracellular cholesterol esterification. Esfahai, M. Swaey, J. B. eds. Advances in Cholesterol Research 1990 The Telford Press Philadelphia, PA. .

15. Chang, C. C., Chen, J., Thomas, M. A., Cheng, D., Del Priore, V. A., Newton, R. S., Pape, M. E. & Chang, T. Y. (1995) Regulation and immunolocalization of acyl-coenzyme A:cholesterol acyltransferase in mammalian cells as studied with specific antibodies. J. Biol. Chem. 270:29532-29540.[Abstract/Free Full Text]

16. Chang, C. C. & Chang, T. Y. (1986) Cycloheximide sensitivity in regulation of acyl coenzyme A:cholesterol acyltransferase activity in Chinese hamster ovary cells. 2. Effect of sterol endogenously synthesized. Biochemistry 25:1700-1706.[Medline]

17. Tabas, I. & Boykow, G. C. (1987) Protein synthesis inhibition in mouse peritoneal macrophages results in increased acyl coenzyme A:cholesterol acyl transferase activity and cholesteryl ester accumulation in the presence of native low density lipoprotein. J. Biol. Chem. 262:12175-12181.[Abstract/Free Full Text]

18. Matsuda, H., Hakamata, H., Miyazaki, A., Sakai, M., Chang, C. C., Chang, T. Y., Kobori, S., Shichiri, M. & Horiuchi, S. (1996) Activation of acyl-coenzyme A:cholesterol acyltransferase activity by cholesterol is not due to altered mRNA levels in HepG2 cells. Biochim. Biophys. Acta 1301:76-84.[Medline]

19. Wang, H., Germain, S. J., Benfield, P. P. & Gillies, P. J. (1996) Gene expression of acyl-coenzyme-A:cholesterol-acyltransferase is upregulated in human monocytes during differentiation and foam cell formation. Arterioscler. Thromb. Vasc. Biol. 16:809-814.[Abstract/Free Full Text]

20. Ghosh, S. & Grogan, W. M. (1989) Activation of rat liver cholesterol ester hydrolase by cAMP-dependent protein kinase and protein kinase C. Lipids 24:733-736.[Medline]

21. Ghosh, S., Kounnas, M. Z. & Grogan, W. M. (1990) Separation and differential activation of rat liver cytosolic cholesteryl ester hydrolase, triglyceride lipase and retinyl palmitate hydrolase by cholestyramine and protein kinases. Lipids 25:221-225.[Medline]

22. Grogan, W. M., Bailey, M. L., Heuman, D. M. & Vlahcevic, Z. R. (1991) Effects of perturbations in hepatic free and esterified cholesterol pools on bile acid synthesis, cholesterol 7 {alpha}-hydroxylase, HMG-CoA reductase, acyl-CoA:cholesterol acyltransferase and cytosolic cholesteryl ester hydrolase. Lipids 26:907-914.[Medline]

23. Ghosh, S., Natarajan, R., Pandak, W. M., Hylemon, P. B. & Grogan, W. M. (1998) Regulation of hepatic neutral cholesteryl ester hydrolase by hormones and changes in cholesterol flux. Am. J. Physiol 274:G662-G668.[Medline]

24. Hegsted, D., McGandy, R. B., Myers, M. L. & Stare, F. J. (1965) Quantitative effects of dietary fat on serum cholesterol in man. Am. J. Clin. Nutr. 17:281-293.[Medline]

25. Mensink, R. P. & Katan, M. B. (1993) Trans monounsaturated fatty acids in nutrition and their impact on serum lipoprotein levels in man. Prog. Lipid Res. 32:111-122.[Medline]

26. Denke, M. A. & Grundy, S. M. (1991) Effects of fats high in stearic acid on lipid and lipoprotein concentrations in men. Am. J. Clin. Nutr. 54:1036-1040.[Abstract/Free Full Text]

27. Tholstrup, T., Marckmann, P., Jespersen, J. & Sandstrom, B. (1994) Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Am. J. Clin. Nutr. 59:371-377.[Abstract/Free Full Text]

28. Zock, P. L., de Vries, J. H. & Katan, M. B. (1994) Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men. Arterioscler. Thromb. 14:567-575.[Abstract/Free Full Text]

29. Spady, D. K. & Dietschy, J. M. (1988) Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J. Clin. Investig. 81:300-309.

30. Knapka, J. J., Smith, K. P. & Judge, F. J. (1974) Effect of open and closed formula rations on the performance of three strains of laboratory mice. Lab Anim. Sci. 24:480-487.[Medline]

31. Schneider, C. L., Cowles, R. L., Stuefer-Powell, C. L. & Carr, T. P. (2000) Dietary stearic acid reduces cholesterol absorption and increases endogenous cholesterol excretion in hamsters fed cereal-based diets. J. Nutr. 130:1232-1238.[Abstract/Free Full Text]

32. Carr, T. P., Andresen, C. J. & Rudel, L. L. (1993) Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 26:39-42.[Medline]

33. Carr, T. P., Cai, G., Lee, J. Y. & Schneider, C. L. (2000) Cholesteryl ester enrichment of plasma low-density lipoproteins in hamsters fed cereal-based diets containing cholesterol. Proc. Soc. Exp. Biol. Med. 223:96-101.[Abstract/Free Full Text]

34. Folch, J., Lees, M. & Sloane-Stanley, G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 224:497-509.

35. Carr, T. P., Parks, J. S. & Rudel, L. L. (1992) Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler. Thromb. 12:1274-1283.[Abstract/Free Full Text]

36. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.[Free Full Text]

37. Grundy, S. M. & Denke, M. A. (1990) Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 31:1149-1172.[Abstract]

38. Ascherio, A., Hennekens, C. H., Buring, J. E., Master, C., Stampfer, M. J. & Willett, W. C. (1994) Trans-fatty acids intake and risk of myocardial infarction. Circulation 89:94-101.[Abstract/Free Full Text]

39. Nicolosi, R. J., Wilson, T. A., Rogers, E. J. & Kritchevsky, D. (1998) Effects of specific fatty acids (8:0, 14:0, cis-18:1, trans-18:1) on plasma lipoproteins, early atherogenic potential, and LDL oxidative properties in the hamster. J. Lipid Res. 39:1972-1980.[Abstract/Free Full Text]

40. Troisi, R., Willett, W. C. & Weiss, S. T. (1992) Trans-fatty acid intake in relation to serum lipid concentrations in adult men. Am. J. Clin. Nutr. 56:1019-1024.[Abstract/Free Full Text]

41. Willett, W. C., Stampfer, M. J., Manson, J. E., Colditz, G. A., Speizer, F. E., Rosner, B. A., Sampson, L. A. & Hennekens, C. H. (1993) Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341:581-585.[Medline]

42. Woollett, L. A. & Dietschy, J. M. (1994) Effect of long-chain fatty acids on low-density-lipoprotein-cholesterol metabolism. Am. J. Clin. Nutr. 60:991S-996S.[Abstract/Free Full Text]

43. Rudel, L. L., Lee, R. G. & Cockman, T. L. (2001) Acyl coenzyme A:cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr. Opin. Lipidol. 12:121-127.[Medline]

44. Lada, A. T. & Rudel, L. L. (2004) Associations of low density lipoprotein particle composition with atherogenicity. Curr. Opin. Lipidol. 15:19-24.[Medline]

45. Johnson, F. L., St Clair, R. W. & Rudel, L. L. (1985) Effects of the degree of saturation of dietary fat on the hepatic production of lipoproteins in the African green monkey. J. Lipid Res. 26:403-417.[Abstract]

46. Rudel, L. L., Haines, J., Sawyer, J. K., Shah, R., Wilson, M. S. & Carr, T. P. (1997) Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. J. Clin. Investig. 100:74-83.[Medline]

47. Salter, A. M., Mangiapane, E. H., Bennett, A. J., Bruce, J. S., Billett, M. A., Anderton, K. L., Marenah, C. B., Lawson, N. & White, D. A. (1998) The effect of different dietary fatty acids on lipoprotein metabolism: concentration-dependent effects of diets enriched in oleic, myristic, palmitic and stearic acids. Br. J. Nutr. 79:195-202.[Medline]

48. Sessions, V. A. & Salter, A. M. (1995) Low density lipoprotein binding to monolayer cultures of hepatocytes isolated from hamsters fed different dietary fatty acids. Biochim. Biophys. Acta 1258:61-69.[Medline]

49. Rumsey, S. C., Galeano, N. F., Lipschitz, B. & Deckelbaum, R. J. (1995) Oleate and other long chain fatty acids stimulate low density lipoprotein receptor activity by enhancing acyl coenzyme A:cholesterol acyltransferase activity and altering intracellular regulatory cholesterol pools in cultured cells. J. Biol. Chem. 270:10008-10016.[Abstract/Free Full Text]

50. Xie, C., Woollett, L. A., Turley, S. D. & Dietschy, J. M. (2002) Fatty acids differentially regulate hepatic cholesteryl ester formation and incorporation into lipoproteins in the liver of the mouse. J. Lipid Res. 43:1508-1519.[Abstract/Free Full Text]

51. Briggs, M. R., Yokoyama, C., Wang, X., Brown, M. S. & Goldstein, J. L. (1993) Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J. Biol. Chem. 268:14490-14496.[Abstract/Free Full Text]

52. Wang, X., Briggs, M. R., Hua, X., Yokoyama, C., Goldstein, J. L. & Brown, M. S. (1993) Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J. Biol. Chem. 268:14497-14504.[Abstract/Free Full Text]

53. Daumerie, C. M., Woollett, L. A. & Dietschy, J. M. (1992) Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proc. Natl. Acad. Sci. U.S.A. 89:10797-10801.[Abstract/Free Full Text]

54. Vasandani, C., Kafrouni, A. I., Caronna, A., Bashmakov, Y., Gotthardt, M., Horton, J. D. & Spady, D. K. (2002) Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. J. Lipid Res. 43:772-784.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
 J. Nutr.Home page
M. Torres-Gonzalez, S. Shrestha, M. Sharman, H. C. Freake, J. S. Volek, and M. L. Fernandez
Carbohydrate Restriction Alters Hepatic Cholesterol Metabolism in Guinea Pigs Fed a Hypercholesterolemic Diet
J. Nutr., October 1, 2007; 137(10): 2219 - 2223.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J.-Y.
Right arrow Articles by Carr, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J.-Y.
Right arrow Articles by Carr, T. P.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]